BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19949580)

  • 1. Very late thrombosis of a drug-eluting stent after discontinuation of dual antiplatelet therapy in a patient treated with both drug-eluting and bare-metal stents.
    Kim SS; Jeong MH; Sim DS; Hong YJ; Kim JH; Ahn YK; Kang JC
    Korean Circ J; 2009 May; 39(5):205-8. PubMed ID: 19949580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents.
    Park DW; Park SW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SJ
    Am J Cardiol; 2007 Mar; 99(6):774-8. PubMed ID: 17350363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
    Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis.
    Bhatt SH; Hauser TH
    Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and prognosis of patients with angiographic stent thrombosis: comparison between drug-eluting and bare-metal stents.
    Le Feuvre C; Helft G; Cohen S; Batisse JP; Barthélémy O; Collet JP; Beygui F; Choussat R; Montalescot G; Metzger JP
    Arch Cardiovasc Dis; 2008 Apr; 101(4):220-5. PubMed ID: 18654096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.
    Pfisterer M; Brunner-La Rocca HP; Buser PT; Rickenbacher P; Hunziker P; Mueller C; Jeger R; Bader F; Osswald S; Kaiser C;
    J Am Coll Cardiol; 2006 Dec; 48(12):2584-91. PubMed ID: 17174201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy in the era of late stent thrombosis.
    Nair R; Simon DI
    Curr Treat Options Cardiovasc Med; 2008 Feb; 10(1):12-7. PubMed ID: 18325303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.
    Shah R; Rao SV; Latham SB; Kandzari DE
    JAMA Cardiol; 2018 Nov; 3(11):1050-1059. PubMed ID: 30383145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
    Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
    J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions.
    Neupane S; Khawaja O; Edla S; Singh H; Othman H; Bossone E; Yamasaki H; Rosman HS; Eggebrecht H; Mehta RH
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):98-104. PubMed ID: 30585391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.
    Fuchs AT; Kuehnl A; Pelisek J; Rolland PH; Mekkaoui C; Netz H; Nikol S
    Endothelium; 2008; 15(1):93-100. PubMed ID: 18568949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late stent thrombosis of bare-metal coronary stent nine years after primary percutaneous coronary intervention.
    Đurić P; Obradović S; Stajić Z; Spasić M; Matunović R; Romanović R; Đenić N; Jović Z
    Vojnosanit Pregl; 2016 Aug; 73(8):774-8. PubMed ID: 29328614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy.
    Pesarini G; Dandale R; Rigamonti A; Pighi M; Zivelonghi C; Mugnolo A; Ferrero V; Vassanelli C; Ribichini F
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1056-65. PubMed ID: 23592553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
    Al-Dehneh A; Virk H; Alkhouri Y; Hamdan A; Bikkina M
    Tex Heart Inst J; 2010; 37(3):343-6. PubMed ID: 20548819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.